Xeris Biopharma Holdings, Inc. Quarterly Quick Ratio in % from Q2 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
The acid-test ratio, also called the quick ratio, is a metric used to see if a company is positioned to sell assets within 90 days to meet immediate expenses.
Summary
Xeris Biopharma Holdings, Inc. quarterly Quick Ratio history and growth rate from Q2 2022 to Q3 2024.
  • Xeris Biopharma Holdings, Inc. Quick Ratio for the quarter ending September 30, 2024 was 50.1 %, a 25.6% increase year-over-year.
Quick Ratio, Quarterly (%)
Quick Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 50.1 +10.2 +25.6% Sep 30, 2024
Q2 2024 48.6 +12.2 +33.5% Jun 30, 2024
Q1 2024 46.1 +14.2 +44.7% Mar 31, 2024
Q4 2023 41.5 +12.4 +42.5% Dec 31, 2023
Q3 2023 39.9 +13.7 +52.4% Sep 30, 2023
Q2 2023 36.4 +9.28 +34.2% Jun 30, 2023
Q1 2023 31.9 Mar 31, 2023
Q4 2022 29.1 Dec 31, 2022
Q3 2022 26.2 Sep 30, 2022
Q2 2022 27.1 Jun 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.